Amgen jilts Kyowa, exiting $400M autoimmune pact after running vast pivotal program
Amgen jilts Kyowa, exiting $400M autoimmune pact after running vast pivotal program
Amgen jilts Kyowa, exiting $400M autoimmune pact after running vast pivotal program